Page 19 - Healthcare Sector

Wockhardt's growth tonic: Covid vaccines add a third prong to biz strategy

In India, Wockhardt aims to make 2 billion doses of Covid-19 vaccines within the next one or two years but has not disclosed the identity of the tie-ups

Biotechnology firm Mylab ropes in Akshay Kumar as brand ambassador

The Pune-based firm, which has a presence across many verticals like diagnostics, food safety, agriculture and veterinary medicine

Covid-19 pandemic: Health ministry flags poor coverage of second dose

The national coverage for the first dose among health care workers is over 82 per cent

Glenmark says interim data from study supports favipiravir's safety

A total of 13 sites across Mumbai, Bengaluru, Hyderabad, Nashik, Nagpur and Trivandrum took part in the study

Apollo Hospitals, Thyrocare: Time to book profits in these stocks?

According to the revised policy, private hospitals will receive 25 per cent of the vaccines and can charge Rs 150 in overhead at max

No govt-owned CT scan machine in 37 of 51 MP districts: Report

MP received Rs 3,712 crore from the State Disaster Relief Management Fund till March this year

Top Headlines: RBI likely to hold interest rates; Softbank to back Flipkart

Our top headlines on Friday track the latest developments

Covid-19 pandemic: PEs pour $584 million into healthcare in 2021

Highest investment in the sector in last 5 years; pandemic expands opportunities

Sun Pharma, Ferring Pharma ink pact to introduce obstetric drug in India

The drug is indicated for the prevention of excessive bleeding in women after vaginal or caesarean childbirth

Do states with 'good' health infra have lower Covid-19 death rates?

it is likely many states would have under-reported data on mortality rates, while misreporting on other key aspects concerning their health sector as well

To use artificial life support, or not to

Throw in the financial consequences and you know that your loved ones will be under tremendous pressure if they have to make this decision

GST meet discussed tax relief on medicines: Maharashtra Deputy CM

Maharashtra Deputy Chief Minister Ajit Pawar said it deliberated on tax relief on medicines, injections and health equipment

Glenmark arm, Emcure, 3 other pharma cos line up Rs 7,000-cr IPOs

The healthcare sector is in the limelight for the second consecutive year

Centre asks state governments to tackle black fungus on a war footing

States have been asked to prepare and implement the infection prevention control programme in hospitals in accordance with the National Guidelines for Infection and Control in Healthcare Facilities

Decoded: What is black fungus and its link to Covid-19 pandemic

India has a huge diabetic population that is at risk. And along with that, steroids and antibiotics are being used quite irrationally for Covid-19 patients

Startup Virohan raises $3 mn, says will train million paramedics by 2025

Company says it has trained over 5,500 people since the pandemic started last year.

Godrej & Boyce expects double-digit growth in healthcare biz going ahead

Consumer goods firm Godrej & Boyce is looking at double-digit growth in its healthcare business going forward, and after the pandemic started in March 2020, it has witnessed a sustained rising demand of its key healthcare products and solutions, said a top company official. Besides, Godrej & Boyce, part of over USD 4.1-billion Godrej Group and a leading maker of medical refrigerators in India, is also quite open to alliance with any vaccine makers such as Pfizer's, that needs to be kept in (-) 70 degrees Celsius. The company's healthcare businesses are growing in the range of 22-25 per cent in the past year, said Godrej & Boyce Executive Director Nyrika Holkar. Godrej & Boyce is operating in the healthcare sector through its multiple step-down subsidiaries, which include Godrej Appliances, Godrej Interio and Godrej Lawkim, in areas such as hospital beds, medical refrigerators and calibration services for medical equipment like ventilators. "We believe that the ...

Returns from healthcare ETFs can be highly cyclical, say analysts

Avoid over 5% exposure and have 5-7 years of investment horizon

Alembic Pharmaceuticals gets USFDA nod for bipolar depression drug

Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression. The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals Inc. The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Lurasidone Hydrochloride tablets in the strengths of 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, Alembic Pharmaceuticals said in a regulatory filing. Quoting IQVIA data, Alembic Pharma said Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg have an estimated market size of USD 3.7 billion for the twelve months ending December 2020. Lurasidone Hydrochloride tablets are indicated for treatment of major depressive episodes associated with bipolar I disorder (bipolar depression). Alembic Pharma said it has settled the cas

Eris Lifesciences Q4 PAT up 21% YoY on strong show by superspecialty biz

Consolidated total income up 13%; robust anti-diabetic sales, new product pipeline, expanded coverage of cardiologists support better numbers